Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma PLC

5 Dec 2005 15:08

HBM BioVentures (Cayman) Ltd05 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) HBM BIOVENTURES (CAYMAN) LTD Company dealt in SKYEPHARMA PLC Class of relevant securityto which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 2 DECEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 63,780,450 (8.46%)(2) Derivatives (other than options) NA (3) Options and agreements to purchase/sell NA Total 63,780,450 (8.46%) (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5)PURCHASE (02.12.2005) 3,003,923 0.523042SALE N/A N/A (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 05 DECEMBER 2005 Contact name JOHN ARNOLD Telephone number +1 345 946 8002 If a connected EFM, name of offeree/offeror with which connected NA If a connected EFM, state nature of connection (Note 10) NA Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th May 20067:02 amRNSConference Call Details
8th May 20067:01 amRNSFlutiform Deal
3rd May 20069:57 amRNSShare Purchase Plan
2nd May 200611:23 amRNSNotification of Shares
28th Apr 20067:02 amRNSEuropean Approval of Depodur
26th Apr 20062:32 pmRNSNotification of Interests
24th Apr 20064:23 pmRNSDirectors Share Awards
24th Apr 20062:29 pmRNSNotification of Interests
24th Apr 20061:38 pmRNSHolding(s) in Company
21st Apr 200611:16 amRNSPropofol Update
19th Apr 20067:02 amRNSPreliminary Results
5th Apr 20062:00 pmRNSBoard Appointment
3rd Apr 20065:43 pmRNSShare Purchase Plan
27th Mar 20069:06 amRNSNotice of Results
17th Mar 200610:15 amRNSNotification of Shares
15th Mar 20062:57 pmRNSNotification of Shares
14th Mar 20067:03 amRNSAgreement over Non-Executives
9th Mar 20063:46 pmRNSResult of EGM
6th Mar 20061:10 pmRNSHolding(s) in Company
3rd Mar 20065:06 pmRNSFinancial Position
3rd Mar 20064:12 pmRNSNotification of Shares
3rd Mar 200610:59 amRNSRule 8.3- Skyepharma PLC
2nd Mar 20064:58 pmRNSResponse to NAV
2nd Mar 20069:59 amRNSResponse to NAV
2nd Mar 20067:40 amRNSEGM Statement
1st Mar 20064:43 pmRNSShare Purchase Plan
27th Feb 20069:37 amRNSEGM Nominee Voting
23rd Feb 20062:14 pmRNSNotification of Shares
23rd Feb 200612:13 pmRNSNotification of Shares
16th Feb 20067:02 amRNSEGM Circular
15th Feb 20063:33 pmRNSDirector/PDMR Shareholding
14th Feb 20065:23 pmRNSNotification of Shares
13th Feb 20065:24 pmRNSNotification of Shares
13th Feb 200610:36 amRNSNotification of Shares
13th Feb 20067:01 amRNSFormer Chairman Retires
9th Feb 20062:34 pmRNSNotification of Shares
9th Feb 200612:35 pmRNSNotification of Shares
9th Feb 20067:01 amRNSFurther Re Employment Terms
8th Feb 20063:33 pmRNSNotification of Shares
7th Feb 20064:29 pmRNSNotification of Shares
7th Feb 20063:30 pmRNSResponse to NAV Syndicate
6th Feb 20063:26 pmRNSNotification of Shares
6th Feb 20063:23 pmRNSNotification of Shares
6th Feb 20067:01 amRNSBoard Appointment
3rd Feb 20063:22 pmRNSNotification of Shares
3rd Feb 200611:19 amRNSDirector Shareholding
3rd Feb 200611:12 amRNSDirector/PDMR Shareholding
3rd Feb 200610:37 amRNSDirector/PDMR Shareholding
2nd Feb 20063:20 pmRNSRule 8.3- (Skyepharma Group)
2nd Feb 200612:08 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.